Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Blood Pressure-Lowering Effects of Aldosterone Synthase Inhibitors in Uncontrolled or Resistant Hypertension: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials

Overall, ASIs have strong short-term placebo-adjusted effects on BP, but direct RCT comparisons between ASIs and MRAs are required; therefore, class comparison is indirect and must be interpreted cautiously.

Girin Ray, D. Sanyal · 0 citations
Review Nov 2026

Impact of Resmetirom on Liver Histology and Metabolic Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Across the Spectrum of Thyroid Status: A Systematic Review

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to metabolic syndrome and to thyroid dysfunction, particularly hypothyroidism, which may weaken Thyroid Hormone Receptor-β (THR-β) signaling in hepatocytes. Resmetirom, an oral liver-directed THR-β agonist, is the first drug...

Girin Ray, D. Sanyal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.